Remove Genetic Disease Remove In-Vitro Remove Pharma Companies
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

To gain insight into the motivations, steps and experiences involved in an academia to industry — or vice versa — transition, Xtalks spoke to several leading scientists and entrepreneurs in pharma and biotech who successfully transitioned from academic positions to leadership roles in industry settings. Key Moments.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

RNA-based therapies hold the potential to offer new treatment options for diseases with limited or inadequate therapeutic alternatives. Gene Editing CRISPR-Cas9 and related gene-editing technologies continue to advance, and today they are widely used to study and develop therapeutic approaches for a broad range of human diseases.